Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EUROIMMUN Anti-BP230-CF ELISA (IgG)

K-Number: K193115 · 2020-09-17

Decision Date2020-09-17
Product CodeOEG
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

EUROIMMUN Anti-BP230-CF ELISA (IgG) is a medical device manufactured by Euroimmun Us, Inc.. It received FDA 510(k) clearance on 2020-09-17 under approval number K193115. The device is classified under product code OEG. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EUROIMMUN Anti-BP230-CF ELISA (IgG)?

EUROIMMUN Anti-BP230-CF ELISA (IgG) is a medical device that received FDA 510(k) clearance on 2020-09-17. It is manufactured by Euroimmun Us, Inc.. The 510(k) number is K193115.

When was EUROIMMUN Anti-BP230-CF ELISA (IgG) approved by the FDA?

EUROIMMUN Anti-BP230-CF ELISA (IgG) received FDA 510(k) clearance on 2020-09-17, under approval number K193115.

What company makes EUROIMMUN Anti-BP230-CF ELISA (IgG)?

EUROIMMUN Anti-BP230-CF ELISA (IgG) is manufactured by Euroimmun Us, Inc..

What is the FDA product code for EUROIMMUN Anti-BP230-CF ELISA (IgG)?

The FDA product code for EUROIMMUN Anti-BP230-CF ELISA (IgG) is OEG.

Other Devices by Euroimmun Us, Inc.

View all 8 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.